Related Experiment Video
Updated: Jul 17, 2026
08:42
Myo-mechanical Analysis of Isolated Skeletal Muscle
Published on: February 22, 2011
Free radical-mediated skeletal muscle dysfunction in inflammatory conditions
Gerald S Supinski1, Leigh A Callahan
1Chandler Medical Center, University of Kentucky, Lexington, KY 40536, USA. gsupi2@email.uky.edu
Journal of Applied Physiology (Bethesda, Md. : 1985)
|January 16, 2007
Summary
Systemic inflammation causes skeletal muscle dysfunction in critical illnesses. Free radicals are key players, directly impacting muscle proteins, cellular structures, and degradation pathways, leading to weakness and mass loss.
Area of Science:
- Muscle physiology and pathophysiology
- Inflammation and oxidative stress
Background:
- Skeletal muscle dysfunction is a major cause of morbidity in critical illnesses like sepsis and cancer.
- Systemic inflammation is a primary driver of muscle weakness, surpassing nutritional deficiency or disuse.
- Free radicals are implicated in modulating inflammation and infection-related muscle dysfunction.
Purpose of the Study:
- To elucidate the role of free radicals in skeletal muscle dysfunction during inflammatory conditions.
- To understand the mechanisms by which free radicals impair muscle function.
Main Methods:
- Review of existing literature on free radical species and their effects on skeletal muscle.
- Analysis of studies investigating the impact of inflammation on muscle contractile proteins, cellular organelles, and degradation pathways.
Main Results:
- Free radical species (e.g., superoxide, nitric oxide) play a critical role in inflammation-induced skeletal muscle dysfunction.
- Free radicals directly alter contractile protein function, sarcoplasmic reticulum, mitochondrial integrity, and sarcolemmal integrity.
- Free radicals modulate proteolytic pathways, potentially affecting protein synthesis and leading to muscle atrophy.
Conclusions:
- Free radicals are central mediators of skeletal muscle dysfunction in inflammatory states.
- Understanding free radical mechanisms is crucial for developing therapeutic strategies to combat muscle weakness in critical illness.
Related Concept Videos
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:28Classification of Skeletal Muscle Relaxants
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...